Spina Bifida: Prevalence, Gender Differences, and Key Facts

Spina bifida is a neural tube defect occurring when the spinal column fails to close completely during early embryonic development (days 21–28 post-conception).

Epidemiology

  • Incidence: ~1 in 2,500 live births globally (varies by region and folate fortification).
  • Gender ratio: Females affected more often than males (~1.2–1.5:1, not 2:1 as sometimes cited).
  • Timing: Present at birth; not acquired later in life.
  • Types: Occulta (mild, often asymptomatic), meningocele, myelomeningocele (most severe, open defect with neural tissue exposure).

Risk Factors

  • Maternal folate deficiency (primary preventable cause)
  • Certain antiseizure medications (valproate, carbamazepine)
  • Maternal diabetes, obesity
  • Family history (recurrence risk ~3–5% after one affected child)
  • Genetic variants in folate pathway genes (MTHFR)

Prevention and Care

  • Folic acid supplementation (400–800 mcg daily) before conception and in early pregnancy reduces risk by ~70%.
  • Prenatal screening (maternal serum AFP, ultrasound) enables early detection.
  • Multidisciplinary lifelong care: neurosurgery, urology, orthopedics, physiatry, neuropsychology.

Genetic Disorders - Related Articles